KPF
SBC

K2 Principal Fund’s SBC Medical Group SBC Stock Holding History

K2 Principal Fund’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,089
Closed -$225K – 304
2023
Q4 		$225K Buy
+21,089
New +$226K 0.03% 162

Other funds holding SBC

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return

K2 Principal Fund's SBC Position: Q1 2024 in Review

K2 Principal Fund sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 21,089 shares — an estimated $225K sold.

K2 Principal Fund first reported a position in SBC in Q4 2023 and held it in 1 quarter. The position peaked at $225K in Q4 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

  • K2 Principal Fund reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
  • K2 Principal Fund sold 21,089 SBC Medical Group shares in Q1 2024, an estimated $225K.
  • K2 Principal Fund first reported a position in SBC Medical Group in Q4 2023 and held it in 1 quarter.
  • K2 Principal Fund's SBC Medical Group position peaked at $225K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on K2 Principal Fund's 13F filing for Q1 2024, filed 14 May 2024.